Loading…
Attending this event?
avatar for Donna Rycroft

Donna Rycroft

AbbVie, United States
Director, Study Risk Management
Strategic Leader in Clinical Development with 11 years expertise in Risk-based Quality Management (RBQM) leading the development, implementation and change management of RBQM models and supporting systems at AbbVie and Allergan. Currently leading a team of Study Risk Leads supporting AbbVie's clinical trial portfolio in risk management activities and leading RBQM initiative on future AI capabilities. Additional Clinical development experience of 20+ years in project and people management in multiple Therapeutic areas.

My Speakers Sessions

Monday, June 17
 

11:00am PDT

#108: Risk Management in Advanced Device Technology Development Room 11AB
 
Share Modal

Share this link via

Or copy link